Cervical cancer (CC) is the fourth most common cause of cancer death in women. The most
important risk factor for the development of CC is cervical infection with human papilloma …

Human papilloma virus (HPV) has emerged as a primary cause of cervical cancer
worldwide. HPV is a relatively small (55 nm in diameter) and non-enveloped virus …

Background Increasing amounts of evidence indicate that tumor infiltrating lymphocytes (TIL)
are correlated with the prognosis of cancer patients. This study focuses on the association …

Human papillomaviruses (HPVs) play a major role in development of cervical cancer, and
HPV oncoproteins are being targeted by immunotherapies. Although these treatments show …

Abstract Although Human Papillomavirus (HPV) exerts a vital influence on cervical
carcinogenesis, other factors influence the development of a squamous intraepithelial lesion …

The recent development of vaccines prophylactic against human papillomavirus (HPV)
infection has the potential to reduce the incidence of cervical cancer globally by up to 70 …

Background. Human papillomaviruses (HPVs) have been proved as one of the etiological
factors of oropharyngeal squamous cell carcinoma (OPSCC). Patients with tumors of viral …

Abstract Interleukin-10 (IL-10) has opposing effects as an anti-inflammatory (potentially
cancer-promoting) and antiangiogenic (potentially cancer-inhibiting) agent. The role of IL-10 …

Only a minority of those exposed to human papillomavirus (HPV) develop HPV-related
cervical and oropharyngeal cancer. Because host immunity affects infection and progression …

A specific immune response to human papillomavirus (HPV) in the cervical
microenvironment plays a key role in eradicating infection and eliminating mutated cells …